Introduction
In vivo results. Peritoneal clearance and MTAC of small solutes (creatinine, urea) were not significantly altered by amino acids or bicarbonate. Peritoneal Despite the fact that continuous ambulatory peritoneal permeability and transperitoneal excretion of higher-dialysis (CAPD) is a safe and well-established treatweight protein molecules ( b 2 -microglobulin, albumin, ment method for patients with end-stage renal failure, IgG ) were increased with Amino/Bic compared to the question of bioincompatibility of conventional Glu/Lac (P<0.05) (D/P ratio albumin: Amino/Bic, dialysis solutions has stimulated increasing interest in 0.027±0.003; Glu/Bic, 0.023±0.003; Glu/Lac, recent years. In vitro experiments gave evidence that 0.022±0.002). Application of Amino/Bic was accom-conventional glucose/lactate-containing dialysis fluids panied by an increased eÄuent concentration of Il-6, have an adverse eÂect on peritoneal host defence [1 ] Il-8, TNFa, PGE 2 , and 6-keto-PGF 1a (P<0.05). while clinical findings demonstrated a negative influDialysate nitrite/nitrate and cGMP concentrations (as ence on patients' glucose, lipid, and protein metabolindicators of NO generation) did not diÂer between ism [2-4 ]. the solutions.
In terms of peritoneal host defence all resident In vitro results. Both bicarbonate fluids demonstrated (mesothelial cells, fibroblasts) and transient (macroa better preservation of the mitochondrial dehydro-phages, neutrophils) cell populations in the peritoneal genases activity (MTT assay) compared to Glu/ cavity interact by a network of immune mediators, Lac (P<0.01) ( Amino/Bic: 80.6±3.2%; Glu/Bic: which seem to be decisive for the potential prevention 86.0±1.8%; Glu/Lac, 64.9±2.3%, referred to RPMI or successful limitation of peritonitis [5, 6 ] . The inhibitas control ). Constitutive and LPS stimulated release ory eÂects of dialysis solutions on peritoneal host of Il-1b and Il-6 was less suppressed with both bicar-defence have been recognized as their low pH especially in combination with lactate as a buÂer [7, 8] , their hyperosmolality [9, 10] , and their high glucose concen-1.5 % glucose solution with 34 mmol/l bicarbonate; Glu/Lac, on fundamental cell functions of macrophages and conventional 1.5% glucose solution with 35 mmol/l lactate polymorphonuclear granulocytes concerning their pha- ( Table 1 ) .
gocytic capacity [9, 12] , the oxidative burst mechanism
Osmolarity of all solutions ranged within narrow limits [13 ] , and their ability to secrete inflammatory cytokines (358-369 mosm/l ), the composition of electrolytes was identand prostanoids [11, [14] [15] . More recently research ical. pH was low in the conventional lactate-buÂered solution has focused on the role of peritoneal mesothelial cells (pH 5.2-5.5 ) and near to physiological levels in both bicarand fibroblasts [16] [17] [18] , and in vitro investigations bonate-buÂered solutions (pH 7.2-7.6). The bicarbonate have demonstrated a harmful eÂect on these cells, fluids were provided in a double-chamber bag to avoid too [19] [20] [21] .
calcium-carbonate precipitation. The two components were
The clinical important issues are metabolic altera-mixed immediately prior to use. tions due to the use of glucose as an osmotic agent. The high glucose absorption from the dialysate is In vivo study associated with hyperinsulinaemia [4 ] and hypertrigly-Patients ceridaemia [2], which are common findings of the so-called metabolic syndrome that could be defined as Ten non-diabetic CAPD patients participated in three 6-h a risk factor for cardiovascular morbidity and mortal-dwell sessions with each test solution. All patients (4 ity. A loss of appetite and reduced protein intake females/6 males) were stable on CAPD and had been free of leading to malnutrition [1] is another negative aspect peritonitis for more than 6 weeks. Mean age was 46.8±11.5, of the high glucose load. BMI 21.9±3.4 (kg/m2). The residual diuresis was less than For these reasons it seemed to be rational consequence 1000 ml/day. All patients had a Kt/V of more than 1.7 and to replace glucose as the osmotic agent and in a second a weekly creatinine clearance of more than 50 l/week. step to replace the buÂer lactate (35-40 mmol/l ) to avoid an acidic dialysate pH (about 5.5). In vivo studies Study design and analytics demonstrated that bicarbonate provided a pysiological pH, was well tolerated, and guaranteed adequate dialysis The trial was designed as a prospective, cross-over random- [22] . It was superior to lactate-buÂered fluids in terms ized, intraindividual study with three diÂerent PD solutions. of biocompatibility as demonstrated by in vitro cell Patients were studied once with each solution after an culture experiments [11, 23 ] .
overnight fast for a 6-h dwell in randomized order. The Amino acids are reported to be well tolerated and intervals between the test phases with each solution ranged from 1 to 3 weeks, during which patients used their convento behave similarly to glucose with regard to ultrafil- amino acid solution with 34 mmol/l bicarbonate; Glu/Bic, before and during the dwell at various time points ( 0, 30, buÂer and resuspended in RPMI 1640 ( Biochrom, Berlin,Germany) with supplements. At a final concentration 60, 120, 240, 360 min).
Osmolarity, pH, creatinine (corrected for glucose interfer-of 2×106 cells/ml the cell suspension was incubated for 90 min at 37°C in a humidified 5% CO 2 atmosphere. After ence) and urea were determined in dialysate and plasma by standard laboratory methods. Proteins (b 2 -microglobulin, washing with prewarmed PBS buÂer the cells were incubated overnight at 4°C to detach the adherent monocytes. After albumin, IgG) were determined by immunonephelometry ( Behring Nephelometer 100, Behring, Marburg, Germany). gently shaking oÂ the monocytes and again washing with PBS the cells were resuspended in PBS buÂer and adjusted Blood and dialysate samples for cytokine and prostanoid measurement were cooled after collection and immediately to a concentration of about 3000 cells/ml. Viability was assessed by the trypan blue exclusion test. Less than 5% centrifuged at 3000 g for 10 min at 4°C to remove cellular components. Blood samples for prostaglandin measurements trypan-blue-positive cells were judged mandatory.
83.0±3.7% of the isolated cell were monocytes according to were stabilized adding EDTA and diclofenac-sodium. Supernatants were stored at −70°C for further analysis.
a naphtyl-acetate-esterase staining (Sigma, Deisenhofen, Germany). The arachidonic acid metabolites PGE 2 , 6-keto-PGF 1a and thromboxane B2 were determined by enzyme immunoTest procedure. The monocytes ( 200 000 cells/ml ) were incubassays after sample extraction (C2, C18 solid phase ated with the test fluids for 45 min in 24-well plates (cytokine columns) (Biotrak-Enzyme immunoassay, Amersham, assay) or 96-well plates (MTT assay). Response curves for Buckinghamshire, UK ); 5 ml plasma and 15 ml dialysate cytokine release and formazan generation were established were extracted ( lower detection limit 1.0, 0.5, 0.5 pg/well during initial time-course experiments with incubation resp.). The samples for cytokine measurement were centriperiods between 0 and 60 min. Forty-five minutes of incubafuged immediately and stored at −70°C. The cytokines Il-1b tion turned out to be adequate to register both the influence (Quantikine High Sensititivity, R&D Systems Europe, of pH and of osmotic agents in the dialysate. Exposure times Abingdon, UK ), TNFa, Il-6 (Cytoscreen ELISA to PDF vary from study to study trying to simulate the Ultrasensitiv, Laboserv GmbH, Giessen, Germany), Il-8 intraperitoneal in vivo situation. In general either 15 to (Cytoscreen ELISA, Laboserv GmbH, Giessen, Germany) 30 min for assessing the eÂect of buÂers [7, 13] or even up to were determined using sandwich ELISAs ( lower detection 2 h prior to assessment of cell function when testing osmotic limit 0.125, 0.5, 0.156, 15.6 pg/ml resp.). cGMP in the agents and/or buÂers were reported [ 32] . The same volume dialysate was measured by a 125I RIA after acetylation using of supplemented RPMI 1640 was added for a further 24 h a second antibody with magnetic beads ( lower detection or 4 h ( MTT) incubation period at 37°C, 5% CO 2 (humidilimit 0.5 pmol/ml )( Amersham Buchler, Braunschweig, fied) to imitate the conditions in the peritoneal cavity with Germany). The specifity of all assays including potential subsequent equilibration of pH and osmolarity and with matrix eÂects (dialysates) was tested for by sample spiking increasing concentration of nutritional factors [33] . After and dilution. As a paramater of potential NO generation addition of RPMI 1640 pH levels ranged between 7.3 and nitrite/nitrate was measured in the dialyate using the Griess 7.8 and osmolarity was between 290 and 330 mosmol/l. reagent.
Cell viability was judged again after 4 h or 24 h with the Ultrafiltration rate was evaluated subtracting the inflow trypan blue test, indicating a survival rate of >90%. dialysate volume from the dialysate eÄuent for the 6-h dwell and were corrected for the cumulative sample volumes taken MTT assay. MTT (Sigma, St Louis, USA) was dissolved in from the dialysate for laboratory analysis ( 235 ml ). One PBS buÂer at 8 mg/ml and filtered to sterilize and remove patient had low ultrafiltration during Glu/Bic application insoluble residue; 10 ml of the cell suspension ( 3000cells/ml in due to an incomplete drainage. This data and derived results PBS) was incubated with 75 ml test sample. After 45 min, were classified as drop out. Clearance rates as well as D/P 10 ml of the MTT reagent and 75 ml RPMI 1640 (including ratios were calculated for creatinine, urea and for protein supplements) was added. After a 4-h incubation SDS plus markers with diÂerent molecular weight (b 2 -microglobulin, 0,01N HCl was added and the culture plates were incubated albumin, IgG). Clearance rates were corrected for the solute overnight to dissolve the formazan product [34 ] . Extinctions removal by the dialysate samples taken. Mass transfer area were measured with an ELISA reader. coeÃcient (MTAC ) was determined for small solutes (creatinine,urea) using the following equation [ 31] :
Cytokines. For this measurement, 1130 ml of the test sample was added to 80 ml cell suspension, 20 ml diluted Pen/Strep (final concentration 1% v/v) and 20 ml of PBS buÂer with or
without LPS (Sigma, St Louis, USA) from E. coli serotype 055:B5 (final concentration of 10 ng/ml; pilot experiments V 1,2 = dialysate volume at time point 0 and 6 h were done to establish a dose-response curves for LPS, 0-100 ng/ml ). After 45 min incubation, 1250 ml supple-
mented RPMI 1640 was added and the cells were incubated for 24 h. Supernatants were centrifugated at 0°C and stored at −70°C for further analysis.
The endotoxin concentration in all solutions was measured C D1,2 = dialysate concentration at time point 0 and 6 h with the limulus amoebocyte lysate QCL-1000 assay from Bio Whittaker (Boehringer, Ingelheim, Germany). In all PD test solutions and media the endotoxin level was determined
In vitro study to be low (∏2 U/l). Preparation of cells. Monocytes were isolated from buÂy coats of healthy volunteers (n=11). Citrated blood was Statistics diluted 151 with PBS-BuÂer (pH: 7.3, 288 mosmol/kg) and centrifuged on a Ficoll Paque (Pharmacia, Uppsala, Sweden) Results are expressed as mean±SEM. Statistical analysis was performed by Student's paired t test and by Wilcoxons density gradient. The interphase cells were washed with PBS-test for prostanoids and cytokines due to a non-parametric measured prostanoids and cytokines did not significdistribution. Bonferroni correction was applied. Linear antly diÂer between all solutions (Figure 1 ) , regression analysis was performed according to Spearman. Amino/Bic instillation was accompanied by a higher Statistical significance was accepted if P<0.05.
concentrations of various prostanoids and cytokines in the dialysate. The concentrations of 6-keto-PGF 1a and PGE 2 in the dialysate after the 6-h dwell were
Results significantly higher with Amino/Bic compared to both glucose dialysates. Due to high interindividual variance In vivo study a statistical diÂerence between Glu/Bic and Glu/Lac could only be found for TxB2, even though prostanoid Clearance and permeabilty. Ultrafiltration rates after a release with Glu/Bic also tended to be somewhat higher 6-h dwell were not significantly diÂerent between the compared to Glu/Lac (Figure 1 ). three fluids (range −68±68 ml/6 h to 51±30 ml/6 h),
The release of Il-1b into the dialysate was similar neither did peritoneal clearance rates for urea and for all solutions (about 0.8 pg/ml, Figure 1 ). The creatinine significantly diÂer between solutions. The dialysate levels of TNFa were significantly increased eÂect of the tested PD solutions on small-solute diÂus-in the Amino/Bic eÄuent compared to the bicarbonate ive transport measured by the mass transfer area or lactate buÂered glucose solution (P<0.05). coeÃcient (MTAC ), also showed comparable eÃcacy However, dialysate levels for both cytokines did not ( Table 2 ) . Concerning the peritoneal permeability of surpass the corresponding serum concentrations. higher weight protein molecules, however, the The diÂerences in cytokine release were even more Amino/Bic solution induced an increased permeability marked for Il-6 and Il-8. After the 6-h dwell Amino/Bic ( D/P ratio fo b 2 -microglobulin, albumin, IgG: Amino/ had a significantly higher Il-8 eÄuent concentration Bic>Glu/Lac, P<0.05; and D/P ratio fo b 2 -micro-(172.7±65.7 pg/ml ) than Glu/Bic and Glu/Lac, that globulin: Amino/Bic>Glu/Bic, P<0.05). The absolute fell near or below the detection limit of the assay excretion rates of total protein and protein marker (<15 pg/ml ). Il-6 levels in the amino-acid dialysate molecules showed a comparable pattern with a total (Amino/Bic, 492.9±121.9 pg/ml ) were also significprotein excretion rate per exchange of 3.05±0.33 g in antly increased after the 6-h dwell compared to the Amino/Bic, 2.77±0.36 g in Glu/Bic, and 2.70±0.25 g glucose-based fluids (Glu/Bic, 143.8±27.3; Glu/Lac, in Glu/Lac (Amino/Bic vs Glu/Lac P<0.05) ( Table 3) .
104.5±23.5; Table 5 ). The dialysate concentrations of Il-8 and Il-6 far exceeded the serum levels (Figure 1 ). Prostanoids and cytokines. Whereas serum levels of all Some correlations could be found between the peritoneal permeability to diÂerent molecular weight pro- ) and of cytokines ( Il-1b, TNFa, Il-6, and Il-8] in the 6-h eÄuent and in the serum when using Amino/Bic, Glu/Bic, and Glu/Lac. The concentrations of vasoactive and potentially permeability-modulating prostanoids and cytokines with high dialysate levels are shown in the figure. Mean values±SEM are shown (n=10).
Prostanoids:
Amino cGMP after a 6-h dwell were 25.7±4.1 pmol/ml in activity of the mitochondrial dehydrogenases compared to Glu/Lac (Amino/Bic, 80.6±3.2%; Glu/Bic, Amino/Bic, 20.8±3.3 pmol/ml in Glu/Bic, and 20.3±2.5 in Glu/Lac (n.s.). With serum concentrations 86.0±1.8%; Glu/Lac, 64.9±2.3%). No significant diÂerence was observed between Amino/Bic and ranging higher and being at equal levels in all test phases (26.1-30.3 pmol/ml ) there was no clear indica-Glu/Bic. tion of an active intraperitoneal cGMP secretion or diÂerences in transperitoneal transport (D/P ratios, Discussion MTAC ). Nitrite/nitrate concentrations in the dialysates were comparable, with 0.46±0.12 mg/ml for The present study confirms that an amino-acid solution Amino/Bic, 0.34±0.11 mg/ml for Glu/Bic, and guarantees adequate dialysis eÃcacy. Clearance capa-0.39±0.08 mg/ml for Glu/Lac (n.s.).
cities, ultrafiltration rates, and mass transfer coeÃ-cients for small solutes were similar in all three In vitro study solutions. Ultrafiltration tended to be only slightly (n.s.) reduced with amino acids which appeared to be Il-1b. Constitutive and LPS stimulated release of Il-1b from mononuclear phagocytes was highest in the clinically irrelevant. Peritoneal small-solute equilibration was also not aÂected when comparing bicarbonate RPMI control medium ( Table 4) . Unstimulated release of Il-1b was less suppressed after incubation with both and lactate as a buÂer (Glu/Lac vs Glu/Bic).
However, in accordance with some earlier reports bicarbonate-buÂered fluids compared to the lactate fluid. LPS stimulated release of Il-1b was significantly [3, 27] we found that the instillation of the amino-acid solution was accompanied by a small but significantly higher in both bicarbonate-buÂered fluids compared to Glu/Lac: RPMI, 2015±329; Amino/Bic, 1166±192; increased peritoneal permeability to higher-weight molecules. The D/P ratios o b 2 -microglobulin, albuGlu/Bic, 752±107; Glu/Lac, 174±51 pg/ml; Table 4 ). No diÂerence was found between the bicarbonate min, and IgG were increased. The absolute excretion rates per exchange of these marker proteins were also solutions.
enhanced especially when comparing Amino/Bic with Glu/Lac. Significance for Amino/Bic against Glu/Bic Il-6. Again constitutive and stimulated release of Il-6 was highest in RPMI control medium ( Table 4) . was only found fo b 2 -microglobulin, due to higher variances in the latter group. From the clinical point Constitutive and LPS stimulated release of Il-6 into the cell supernatant was significantly less suppressed of view, with regard to nutritional aspects, the small increase of transperitoneal protein loss was not relevant in both bicarbonate solutions compared to Glu/Lac ( LPS stimulation: RPMI, 1312±180; Amino/Bic, in the light of a clearly positive protein nitrogen balance that was achieved by amino acid absorption 409±88; Glu/Bic, 827±196; Glu/Lac, 12±3 pg/ml ].
from the dialysate (data not shown). Steinhauer et al. also found enhanced D/P ratios for MTT test. Incubation of monocytes in RPMI medium resulted in the highest cellular formazan generation protein markers when using a combined 2.6% amino acid/0.55% glucose solution buÂered with lactate. They and was used as internal control (100% reference value, Table 4 ). Both bicarbonate-buÂered CAPD fluids dem-attributed his finding to an increased eÄuent concentration of PGE 2 [27] . But other studies did not confirm onstrated a significantly better preserved (P<0.01) these results [24, 25] . The study designs used, however, ured as an indicator of NO activity. No diÂerences in nitrite/nitrate concentrations (the stable end products were not always well suited to answer this question. In this study the increase in peritoneal permeability of oxidized NO) could be found between the test solutions. Also cGMP dialysate concentrations did not was associated with a marked elevation of potentially permeability increasing mediators (PGE 2 , 6-keto-diÂer between the amino acid and glucose-containing solutions. As cGMP is a relatively small solute it easily PGF 1a , TNFa, Il-6 and Il-8 ) in the dialysate after a 6-h dwell with Amino/Bic [36] [37] [38] . Therefore a causal diÂuses from the blood space into the dialysate. We could not find increased dialysate levels compared to relation seems probable. However, the statistical correlations between the eÄuent concentrations of the plasma values as an indicator of active intraperitoneal secretion. These findings are in agreement with Douma mentioned mediators and the peritoneal permeability markers were often only at the edge of significance. et al. who also did not find significant intraperitoneal NO or cGMP formation when using an amino acid/ The best correlation could be found for IL-6. This might be due to the low number of patients (n=10) lactate dialysate (NutrinealB). However, they showed an increase in small solute MTAC with this solution and the high inter-and intraindividual variance of prostanoid and cytokine concentrations [39] . The peri-with an unchanged restriction coeÃcient [28 ] .
Unfortunately it is not possible to get a 'positive' or toneal transport is influenced by two distinct properties: the eÂective surface area of the peritoneum, which 'physiological' control in CAPD (since PD is an unphysiological situation per se) indicating whether is dependent on peritoneal blood flow, and the intrinsic permeability to macromolecules. As we did not observe higher levels of the mentioned mediators with Amino/Bic indicate a more physiological situation, i.e. a significant change in the MTAC of low-molecularweight solutes (creatinine) an influence of Amino/Bic less suppression of cell function, or are the expression of an underlying inflammatory activity compared to on eÂective perioneal surface area (induced by vasodilatation) seemed to be of minor importance. The per-the situation with Glu/Lac. For this reason we have done some further in vitro experiments on monocytes/ meability-increasing properties of prostanoids and cytokines appeared to be prevailing. Mican et al.
[36 ] macrophages.
Incubation of mononuclear phagocytes with both demontrated a role of Il-6 for increased vasopermeability during anaphylactic reactions in the skin of bicarbonate-buÂered fluids resulted in higher LPSstimulated release of Il-1b and Il-6 compared to mice and Colletti et al.
[37] showed the same properties for TNFa in the human capillary system of the lung. Glu/Lac. The constitutive and LPS stimulated cytokine release after incubation of monocytes with both bicarInterestingly Zemel et al. [39 ] also oberved a significant positive correlation between dialysate Il-6 concentra-bonate fluids, however, was still lower than in the optimum reference culture medium RPMI 1640. We tions and the intrinsic permeability of the peritoneum in stable CAPD patients without pertonitis. The per-therefore conclude that Amino/Bic and Glu/Bic did not induce a specific cellular stimulation but led to less meability-increasing eÂects of prostanoids (PGE 2 , 6-keto-PGF 1a ) are well described [38 ] . Interestingly inhibition of monocyte response compared to Glu/Lac. Constitutive release of Il-1b and Il-6 (related to cell even TxB2, which is known to possess vasoconstricting rather than dilatating properties, was increased in the number or cell protein concentration) was higher in this study than in other reports [32] . We attribute this eÄuent of both bicarbonate fluids compared to Glu/Lac. We conclude that Amino/Bic application was finding to the fact that not only PBMC were isolated from the blood, but specifically monocytes, which associated with an elevated permeability to higherweight molecules most probably because of an represent the first line of defence in infection-free PD patients. Adhesion of phagocytes to polystyrol and increased intraperitoneal generation of vasoactive mediators. In the case of Amino/Bic Il-8, Il-6, and subsequent detachment was performed, which may have induced a higher basal cellular activation. 6-keto-PFG 1a eÄuent concentrations exceeded serum levels indicating active peritoneal synthesis rather than Nevertheless a manifold cytokine stimulation by LPS could be induced, and revealed marked diÂerences with passive diÂusion. The dialysate/serum ratios of Il-1b and PGE 2 and the D/P ratios of protein markers (e.g a clearly suppressed Il-1b and Il-6 release under incubation with Glu/Lac. Oxidative cell metabolism as b 2 -microglobulin or albumin which are not synthesized within the peritoneal cavity) did not show any correla-assessed with an MTT assay via measurement of mitochondrial dehydrogenases activity showed less tion (data not shown), thereby indicating intraperitoneal secretion of these mediators, too, rather than cytotoxicity with both bicarbonate-buÂered solutions.
In contrast to the in vivo results both bicarbonatemere diÂusive transport [39 ] .
The amino acid solution contained L-arginine which buÂered fluids, whether glucose or amino acid based, did not diÂer so much in terms of in vitro IL-6 release is a substrate for nitric-oxide synthesis. NO (or endothelium-derived relaxing factor) is involved in many (with Glu/Bic even slightly higher) and were to the same extent superior to the lactate-buÂered dialysate vasodilating processes. This may suggest that nitric oxide may also play a role in the regulation of periton-with regard to stimulated Il-1b release.
Taken together our in vitro experiments clearly coneal permeability. NO activates the intracellular soluble guanylate cyclase, resulting in an increase of cGMP firmed the superiority of bicarbonate as a buÂer in combination with glucose as well as with amino acids. formation. The latter shows a rapid equilibrium with the extracellular space. Thereby cGMP can be meas-There are only few reports about in vitro testing of 1-1.5% amino-acid solutions. Schenk et al. [29 ] found instead of a lactate buÂer, both with glucose and amino-acid-based solutions. Further basic research on a compromised oxidative metabolism and killing capacity of PMNs with 1% and 1.5% amino acids compared the influence of amino acids and other osmotic agents on the cytokine/prostanoid network within the peritonto glucose-based fluids. Jö rres et al. [30] 
